{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-002664","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.228234+00:00","generated_at":"2026-05-27T03:30:02.074470+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pulse Biosciences appoints Jon Skinner as CFO effective Feb 3, 2025","bullets":["Jon Skinner appointed CFO effective Feb 3, 2025; previously VP at Copeland and Imperative Care.","Annual base salary $400,000, target bonus 50% of salary, sign-on bonus up to $56,000.","Granted option for 300,000 shares at $20.93 (closing on Jan 31, 2025) with four-year vesting.","Half of options vest time-based over 4 years; half vest based on market cap and revenue milestones.","Milestones include market caps of $2B to $5B and GAAP product revenues of $8M to $175M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-002664","json":"https://secwatch.observer/filing/0001437749-25-002664.json","markdown":"https://secwatch.observer/filing/0001437749-25-002664.md","text":"https://secwatch.observer/filing/0001437749-25-002664.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/0001437749-25-002664-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/plse20250131_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:30:02.074470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a0c463ff5c","claim":"Jon Skinner was appointed as Chief Financial Officer at PULSE BIOSCIENCES, INC..","evidence_excerpt":"Pulse Biosciences, Inc. (the “Company”) has appointed Jon Skinner as Chief Financial Officer of the Company, effective as of February 3, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/0001437749-25-002664-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}